Paul Peter Tak - 08 Dec 2022 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Executive Officer, Director
Signature
/s/ Jason A. Amello, as Attorney-in-Fact for Paul Peter Tak
Issuer symbol
CADL
Transactions as of
08 Dec 2022
Net transactions value
+$30,020
Form type
4
Filing time
12 Dec 2022, 15:25:25 UTC
Previous filing
30 Nov 2022
Next filing
02 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Purchase $5,185 +3,050 +12% $1.70 28,050 08 Dec 2022 Direct F1
transaction CADL Common Stock Purchase $24,835 +12,935 +46% $1.92 40,985 09 Dec 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.89 to $2.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.